<DOC>
	<DOCNO>NCT00625365</DOCNO>
	<brief_summary>The purpose registry study gather safety information current clinical use safety DEFINITY®</brief_summary>
	<brief_title>A Prospective , Phase IV , Surveillance Registry Study Evaluate Safety DEFINITY® Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Inclusion criterion Patients , investigator 's opinion , require DEFINITY® echocardiography due suboptimal , unenhanced image . Exclusion criterion Known hypersensitivity perflutren , DEFINITY® , echo contrast agent . Prior SAE associate perflutren , DEFINITY® , administration echo contrast agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>DEFINITY</keyword>
	<keyword>Safety</keyword>
	<keyword>Survelliance</keyword>
</DOC>